the problem

Neonatal abstinence syndrome is one of the most pressing medical and social problems we face today. 5.4% of women report drug use during pregnancy.

Substance Use Disorder (SUD) Defined

Primary, chronic disease of brain reward, motivation, memory, and related circuitry...

Society of Addiction Medicine (ASAM)

Complex, chronic, relapsing

Addiction is a disease of the brain


SUD affects all socioeconomic, gender, race & ethnic groups

Craving & compulsivity

Continued use despite harmful consequences

Impaired executive function

Perception, learning, impulse control & judgment are altered

SUD is characterized by
  • Genetic predisposition
  • Significant self-deception
  • History of trauma
  • Co-occurring psychiatric illness

Did you know?

Opioid addiction can alter one's life-sustaining activities

Opioid misuse affects the dopamine reward system located in the brain’s limbic system and can impair one’s interest in eating, sleeping, moving and sex — all requirements for sustaining life.

Opioids can also alter emotion, cognition, motivation, judgment, decision-making and one’s response to pain and pleasure.

Pregnancy & SUD

Pregnancy is a motivator for change, and with support, it can be a pivotal point to seek treatment for substance use disorder.

1 in 4 pregnant women

have filled a prescription for opiates

1 in 20 women

are pregnant at entry into treatment

1 in 20 pregnant women

report current marijuana use

3 in 5 substance affected

pregnancies are paid for by Medicaid

Pregnant Women

with SUD have a high rate of depression, anxiety and bipolar disease.

Women with SUD

have less joy, energy and exhibit altered parenting due to decreased dopamine and oxytocin.

Did you know?

SUD adds many challenges in pregnancy
Challenges include:
  • Housing insecurity
  • Unemployment
  • Poor nutrition
  • Poverty
  • Transportation barriers
  • Inadequate child care
  • Limited support system
  • CPS & custody issues
  • Undiagnosed/untreated mental illness
  • Limited addiction treatment options

Neonatal Abstinence Syndrome

NAS is one of the most pressing medical and social problems faced today.

K. Dawn Forbes, MD

6.3% of opioid exposed infants

have an IQ 2 standard deviations below normal

17% of opioid exposed infants

are born prematurely

60% of opioid exposed infants

require withdrawal treatment leading to additional opioid exposure

78% of infants with NAS in the U.S.

are covered by Medicaid

Average treatment cost

$93,400 per infant with neonatal withdrawal

Aggregate cost of care

More than $2.5 billion for infants with neonatal withdrawal

Did you know?

Newborns are NOT addicts; they are NOT addicted

When infants are exposed to opioids in utero they can develop a dependency on the opioid. After birth, when exposure stops, they are at risk of going through a self-limited withdrawal which can be treated with comfort measures and, as needed, opiate medication.

Our solution


the NAS experience See our solution